QIAGEN NVQIAGEN NVQIAGEN NV

QIAGEN NV

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪9.17 B‬EUR
0.3844EUR
‪309.22 M‬EUR
‪1.78 B‬EUR
‪216.53 M‬
Beta (1Y)
0.58
Employees (FY)
‪5.97 K‬
Change (1Y)
−211 −3.42%
Revenue / Employee (1Y)
‪298.41 K‬EUR
Net income / Employee (1Y)
‪51.82 K‬EUR

About Qiagen N.V.


CEO
Thierry Bernard
Website
Headquarters
Venlo
Founded
1996
ISIN
NL0015002CX3
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
A3L06J
QIAGEN 24/31 CV
Yield to maturity
2.48%
Maturity date
Sep 10, 2031
QGEN5328376
QIAGEN N.V. 0.0% 17-DEC-2027
Yield to maturity
1.97%
Maturity date
Dec 17, 2027

Explore more bonds 

Frequently Asked Questions


The current price of A40ZZU is 40.8850 EUR — it has decreased by −4.66% in the past 24 hours. Watch QIAGEN NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange QIAGEN NV stocks are traded under the ticker A40ZZU.
A40ZZU stock has fallen by −3.36% compared to the previous week, the month change is a −3.36% fall, over the last year QIAGEN NV has showed a −2.85% decrease.
We've gathered analysts' opinions on QIAGEN NV future price: according to them, A40ZZU price has a max estimate of 59.44 EUR and a min estimate of 43.34 EUR. Watch A40ZZU chart and read a more detailed QIAGEN NV stock forecast: see what analysts think of QIAGEN NV and suggest that you do with its stocks.
A40ZZU reached its all-time high on Jan 30, 2025 with the price of 42.0850 EUR, and its all-time low was 42.0850 EUR and was reached on Jan 30, 2025. View more price dynamics on A40ZZU chart.
See other stocks reaching their highest and lowest prices.
A40ZZU stock is 5.58% volatile and has beta coefficient of 0.58. Track QIAGEN NV stock price on the chart and check out the list of the most volatile stocks — is QIAGEN NV there?
Yes, you can track QIAGEN NV financials in yearly and quarterly reports right on TradingView.
QIAGEN NV is going to release the next earnings report on May 5, 2025. Keep track of upcoming events with our Earnings Calendar.
A40ZZU earnings for the last quarter are 0.59 EUR per share, whereas the estimation was 0.60 EUR resulting in a −1.02% surprise. The estimated earnings for the next quarter are 0.47 EUR per share. See more details about QIAGEN NV earnings.
QIAGEN NV revenue for the last quarter amounts to ‪503.27 M‬ EUR, despite the estimated figure of ‪503.32 M‬ EUR. In the next quarter, revenue is expected to reach ‪451.46 M‬ EUR.
A40ZZU net income for the last quarter is ‪88.07 M‬ EUR, while the quarter before that showed ‪−171.28 M‬ EUR of net income which accounts for 151.42% change. Track more QIAGEN NV financial stats to get the full picture.
QIAGEN NV dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 7, 2025, the company has ‪5.97 K‬ employees. See our rating of the largest employees — is QIAGEN NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. QIAGEN NV EBITDA is ‪611.86 M‬ EUR, and current EBITDA margin is 33.10%. See more stats in QIAGEN NV financial statements.
Like other stocks, A40ZZU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QIAGEN NV stock right from TradingView charts — choose your broker and connect to your account.